Efficacy of subsequent docetaxel plus /- ramucirumab and S-1 after nivolumab for patients with advanced non-small cell lung cancer

Tamura, N; Horinouchi, H; Sekine, K; Matsumoto, Y; Murakami, S; Goto, Y; Kanda, S; Fujiwara, Y; Yamamoto, N; Ohe, Y

Horinouchi, H (reprint author), Natl Canc Ctr, Dept Thorac Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.

THORACIC CANCER, 2019; 10 (5): 1141

Abstract

Background Cytotoxic chemotherapy for advanced non-small cell lung cancer (NSCLC) as second-line or subsequent treatment generally results in a poor t......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索